Most recent by Ana-Maria Orbai, MD, MHS
VIDEO: Early screening 'critical' in psoriatic arthritis
Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.
VIDEO: What psoriatic arthritis awareness means for clinicians, patients
Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.
VIDEO: Advancements in the pipeline for psoriatic arthritis
Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.
VIDEO: Practice-changing approvals in psoriatic arthritis
Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.
VIDEO: Impact of structural racism, personal bias in health care on psoriatic arthritis
Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.
VIDEO: JAK inhibitors' impact on the treatment landscape of psoriatic arthritis
Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.